Meadow Creek Investment Management’s Core Laboratories CLB Stock Holding History

Meadow Creek Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$493K	Buy	10,574 +2,006	+23%	+$93.3K	0.01%	731
2019 Q2	$448K	Hold	8,568	–	–	0.01%	761
2019 Q1	$591K	Hold	8,568	–	–	0.01%	626
2018 Q4	$511K	Hold	8,568	–	–	0.01%	612
2018 Q3	$992K	Buy	8,568 +1,156	+16%	+$130K	0.02%	465
2018 Q2	$935K	Sell	7,412 -1,394	-16%	-$170K	0.02%	454
2018 Q1	$953K	Sell	8,806 -3,230	-27%	-$357K	0.02%	441
2017 Q4	$1.32M	Sell	12,036 -3,842	-24%	-$383K	0.03%	392
2017 Q3	$1.57M	Buy	15,878 +5,168	+48%	+$501K	0.04%	326
2017 Q2	$1.08M	Sell	10,710 -3,604	-25%	-$389K	0.03%	395
2017 Q1	$1.65M	Hold	14,314	–	–	0.04%	322
2016 Q4	$1.72M	Buy	+14,314	New	+$1.58M	0.04%	299

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meadow Creek Investment Management's CLB Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Core Laboratories (CLB) stake by 23% in Q3 2019, buying an estimated $93.3K and bringing the position to 10,574 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #731.

Meadow Creek Investment Management first reported a position in CLB in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.72M in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Meadow Creek Investment Management held 10,574 shares of Core Laboratories worth $493K as of Q3 2019.
Meadow Creek Investment Management bought 2,006 Core Laboratories shares in Q3 2019, an estimated $93.3K.
Core Laboratories made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #731 holding.
Meadow Creek Investment Management first reported a position in Core Laboratories in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Core Laboratories position peaked at $1.72M in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.